Literature DB >> 8764794

Etiology of choroidal neovascularization in young patients.

S Y Cohen1, A Laroche, Y Leguen, G Soubrane, G J Coscas.   

Abstract

BACKGROUND: Choroidal neovascularization (CNV) is a common cause of legal blindness in developed countries. In patients younger than 50 years of age, CNV can be due to various causes, but to the authors' knowledge there has been no large epidemiologic study to compare the relative incidence of the various causes of CNV in this younger-aged group.
METHODS: A retrospective study was performed of patients seen over a 30-month period to precisely define the relative incidence of the various etiologies of CNV in patients younger than 50 years of age who had been referred to a tertiary care ophthalmology department in western Europe.
RESULTS: Clinical charts and angiograms of 363 patients were reviewed. The etiology of CNV was high myopia in 225 (62%) patients, pseudo-presumed ocular histoplasmosis syndrome in 42 (12%), angioid streaks in 17 (5%), and miscellaneous hereditary or traumatic or inflammatory disorders in 16 (4%). Choroidal neovascularization could not be related to any etiology in 63 (17%) patients, and was considered to be idiopathic lesions. Choroidal neovascularization was subfoveal in 62% of the patients due to myopia versus 30% to 36% in patients due to other etiologies. Laser photocoagulation was applied in the majority of patients due to all etiologies except myopia.
CONCLUSION: These data provide the relative incidence of the various etiologies of CNV in young patients and emphasize the importance of myopia as an etiology of CNV in such patients. In addition, an apparent preferential localization of CNV to the subfoveal region in myopic eyes precludes its treatment with photocoagulation.

Entities:  

Mesh:

Year:  1996        PMID: 8764794     DOI: 10.1016/s0161-6420(96)30515-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  69 in total

1.  Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients.

Authors:  J M Ruiz-Moreno; C de la Vega
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  [Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results].

Authors:  J Wachtlin; A Wehner; H Heimann; M H Foerster
Journal:  Ophthalmologe       Date:  2004-05       Impact factor: 1.059

3.  Contrast sensitivity after intravitreal antivascular endothelial growth factor therapy for myopic choroidal neovascularization.

Authors:  Sarah Moussa; Siamak Ansari-Shahrezaei; Eva Smretschnig; Stefan Hagen; Kerstin Steindl-Kuscher; Ilse Krebs; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-16       Impact factor: 3.117

Review 4.  Optical coherence tomography and pathological myopia: an update of the literature.

Authors:  Maria Vittoria Cicinelli; Luisa Pierro; Marco Gagliardi; Francesco Bandello
Journal:  Int Ophthalmol       Date:  2015-08-12       Impact factor: 2.031

5.  Spectral-domain optical coherence tomography of macula in myopia.

Authors:  Janejit Choovuthayakorn; Taksaorn Laowong; Nawat Watanachai; Direk Patikulsila; Voraporn Chaikitmongkol
Journal:  Int Ophthalmol       Date:  2015-08-20       Impact factor: 2.031

6.  A case of idiopathic choroidal neovascular membrane in a young patient.

Authors:  M A Khan; Shabnam Bhalla; V S Gurunadh; V K Mohindra; Sridhara Reddy
Journal:  Med J Armed Forces India       Date:  2015-02-16

Review 7.  Choroidal neovascularisation in pathological myopia: an update in management.

Authors:  W-M Chan; M Ohji; T Y Y Lai; D T L Liu; Y Tano; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

8.  Genomewide scan in Ashkenazi Jewish families demonstrates evidence of linkage of ocular refraction to a QTL on chromosome 1p36.

Authors:  Robert Wojciechowski; Chris Moy; Elise Ciner; Grace Ibay; Lauren Reider; Joan E Bailey-Wilson; Dwight Stambolian
Journal:  Hum Genet       Date:  2006-02-24       Impact factor: 4.132

9.  Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Authors:  P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

10.  Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy.

Authors:  Kengo Hayashi; Kyoko Ohno-Matsui; Noriaki Shimada; Muka Moriyama; Wakako Hara; Takeshi Yoshida; Takashi Tokoro; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.